Lv4
469 积分 2025-12-17 加入
Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma
4天前
已完结
Magnetic Resonance-guided Procedures: Consensus on Rationale, Techniques, and Outcomes
9天前
已完结
Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis
19天前
已完结
Measuring inconsistency in meta-analyses
19天前
已完结
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints
19天前
已完结
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
19天前
已完结
Real-World Evidence — What Is It and What Can It Tell Us?
19天前
已完结
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
19天前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
19天前
已完结
Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study
1个月前
已完结
皖公网安备34019202002308
